Conservative management of esophageal perforation following obesity surgery.
BACKGROUND
Laparoscopic adjustable silicone gastric banding (LASGB) is one of the several surgical techniques for treating patients with morbid obesity. Erosion and perforation in the gastric chamber caused by LASGB are rare complications that have already been described. There have not yet been any reports of perforation of the middle esophagus during this procedure.


METHODS
The authors describe the case of a patient who presented the complication of very extensive perforation of the middle third of the esophagus following LASGB. This was successfully managed using conservative treatment.
Ardengh
José Celso
JC
Hospital Israelita Albert Einstein, São Paulo, Brazil. jcelso@uol.com.br
Domene
Carlos Eduardo
CE
Valiati
Loana Heuko
LH
Morrell
Alexander Charles
AC
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D004750:Enteral Nutrition; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004939:Esophageal Perforation / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015391:Gastroplasty / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D010535:Laparoscopy / Q000009:adverse effects*; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D009853:Omeprazole / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D008795:Metronidazole; D002443:Ceftriaxone; D009853:Omeprazole